Integrated Care for Atrial Fibrillation Using the ABC Pathway in the Prospective APHRS-AF Registry
Tommaso Bucci(University of Liverpool), Tze‐Fan Chao(National Yang Ming Chiao Tung University), Marco Proietti(University of Milan), Gregory Y.H. Lip(Medical University of Białystok), Giulio Francesco Romiti(University of Liverpool), Hung‐Fat Tse(University of Hong Kong), Hyung Wook Park(Chonnam National University Hospital), Alena Shantsila(University of Liverpool), Wee‐Siong Teo(National Heart Centre Singapore), Wataru Shimizu(Nippon Medical School Hospital)
Cited by 52
Related Papers
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
|European Journal of Heart Failure|2012|2.6k
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
|European Heart Journal|2016|2.5k
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
|European Heart Journal|2018|2.1k
2016 ESC Position Paper on Cancer Treatments and Cardiovascular Toxicity Developed Under the Auspices of the ESC Committee for Practice Guidelines
|European Journal of Heart Failure|2016|1.8k